MIPI

Molecular Insight Pharmaceuticals (MM) (MIPI)

Molecular Insight Pharmaceuticals (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MIPI

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
03/12/2010	12:50PM	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
03/10/2010	5:25PM	Edgar (US Regulatory)	Amended Quarterly Report (10-Q/A)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
02/21/2010	10:50PM	GlobeNewswire Inc.	Biotech Stock Alert for Molecular Insight Pharmaceuticals Inc. Issued by Beacon Equity	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
02/19/2010	1:25AM	GlobeNewswire Inc.	Skymark Research Initiates Independent Research Coverage on Molecular Insight Pharmaceuticals, Inc.	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
02/16/2010	9:39PM	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
02/16/2010	4:56PM	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
02/08/2010	11:29AM	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
01/27/2010	4:34PM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
01/27/2010	4:01PM	Marketwired	Molecular Insight Announces Updates to Board of Directors	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
01/21/2010	10:29AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
01/07/2010	4:01PM	Marketwired	Molecular Insight Pharmaceuticals Announces Personnel Reduction to Align Operations With Development Activities	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
01/06/2010	2:28PM	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
01/06/2010	2:08PM	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
12/28/2009	6:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
12/28/2009	5:50PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
12/03/2009	10:38AM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
11/24/2009	4:23PM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
11/24/2009	4:01PM	Marketwired	Molecular Insight Pharmaceuticals Announces Changes to Board	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
11/18/2009	9:56PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
11/11/2009	3:12PM	Marketwired	Molecular Insight Pharmaceuticals to Present at Lazard Capital Markets Annual Healthcare Conference	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
11/09/2009	4:09PM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
11/09/2009	4:01PM	Marketwired	Molecular Insight Pharmaceuticals Reports Third Quarter 2009 Financial Results	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
11/09/2009	6:03AM	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
10/26/2009	8:30AM	Marketwired	Molecular Insight Pharmaceuticals, Inc. to Report Third Quarter Financial Results on November 9, 2009	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
10/23/2009	6:02AM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
10/21/2009	8:30AM	Marketwired	Molecular Insight Pharmaceuticals Finalizes Onalta(TM) Manufacturing and Supply Agreements	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
10/05/2009	8:34AM	Marketwired	Molecular Insight Pharmaceuticals Presents Azedra(TM) 12-Month Efficacy Data From Phase I Clinical Trial in Neuroendocrine Tumor	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
09/14/2009	6:00AM	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
09/04/2009	4:06PM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
09/04/2009	10:12AM	Marketwired	Molecular Insight Pharmaceuticals, Inc. to Present at Rodman and Renshaw 11th Annual Healthcare Conference	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)